Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Life Sciences

Dartmouth College

Series

2013

Candida albicans

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

Correction: Differential Adaptation Of Candida Albicans In Vivo Modulates Immune Recognition By Dectin-1, Mohlopheni J. Marakalala, Simon Vautier, Joanna Potrykus, Louise A. Walker, Kelly M. Shepardson, Alex Hopke, Hector M. Mora-Montes, Ann Kerrigan, Mihai G. Netea, Graeme I. Murray, Donna M. Maccallum, Robert Wheeler, Carol A. Munro, Neil A. R Gow, Robert A. Cramer, Alistair J. P Brown, Gordon D. Brown Apr 2013

Correction: Differential Adaptation Of Candida Albicans In Vivo Modulates Immune Recognition By Dectin-1, Mohlopheni J. Marakalala, Simon Vautier, Joanna Potrykus, Louise A. Walker, Kelly M. Shepardson, Alex Hopke, Hector M. Mora-Montes, Ann Kerrigan, Mihai G. Netea, Graeme I. Murray, Donna M. Maccallum, Robert Wheeler, Carol A. Munro, Neil A. R Gow, Robert A. Cramer, Alistair J. P Brown, Gordon D. Brown

Dartmouth Scholarship

The b -glucan receptor Dectin-1 is a member of the C-type lectin family and functions as an innate pattern recognition receptor in antifungal immunity. In both mouse and man, Dectin-1 has been found to play an essential role in controlling infections with Candida albicans , a normally commensal fungus in man which can cause superficial mucocutaneous infections as well as life-threatening invasive diseases. Here, using in vivo models of infection, we show that the requirement for Dectin-1 in the control of systemic Candida albicans infections is fungal strain-specific; a phenotype that only becomes apparent during infection and cannot be recapitulated …


Control Of Candida Albicans Metabolism And Biofilm Formation By Pseudomonas Aeruginosa Phenazines, Diana K. Morales, Nora Grahl, Chinweike Okegbe, Lars E. P. Dietrich, Nicholas J. Jacobs, Deborah A. Hogan Jan 2013

Control Of Candida Albicans Metabolism And Biofilm Formation By Pseudomonas Aeruginosa Phenazines, Diana K. Morales, Nora Grahl, Chinweike Okegbe, Lars E. P. Dietrich, Nicholas J. Jacobs, Deborah A. Hogan

Dartmouth Scholarship

Candidaalbicanshasdevelopmentalprogramsthatgoverntransitionsbetweenyeastandfilamentousmorphologies and between unattached and biofilm lifestyles. Here, we report that filamentation, intercellular adherence, and biofilm develop- ment were inhibited during interactions between Candida albicans and Pseudomonas aeruginosa through the action of P. aeruginosa-produced phenazines. While phenazines are toxic to C. albicans at millimolar concentrations, we found that lower concentrations of any of three different phenazines (pyocyanin, phenazine methosulfate, and phenazine-1-carboxylate) allowed growth but affected the development of C. albicans wrinkled colony biofilms and inhibited the fungal yeast-to-filament transition. Phenazines impaired C. albicans growth on nonfermentable carbon sources and led to increased production of fer- mentation products (ethanol, glycerol, and …